Pharmacy mark-ups in question, cash-patient earnings mostly insulated, radio-pharmaceutical handling costs explaining the headline, insurance package rates buffering the hit, what’s in store for hospital stocks now? India’s hospital sector is working through a regulatory scare that analysts have been bracing for since the DPCO cycle of 2013 — andContinue Reading

Large caps stabilising, mid-tiers outperforming, AI deflation weighing on guidance across the globe  The Indian IT sector has had a complicated year. Growth has been modest. Guidance cuts have arrived from Accenture, Infosys, Cognizant and others. And yet the stocks have rallied — supported by reasonable valuations, attractive dividend yieldsContinue Reading

Order inflows up 19%, government capex running ahead of last year’s pace, thermal upcycle intact, transformer availability improving The West Asia conflict has been the single most disruptive variable in India’s capital goods sector through FY27 — affecting EPC companies with Middle East exposure, pushing commodity prices higher and slowingContinue Reading